FAS
bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true nocite: | @paneaWholeGenomeLandscape2019, @spinaGeneticsNodalMarginal2016, @morinFrequentMutationHistonemodifying2011, @schollMutationsRegionFAS2007, @wohlfartFASCD95Mutations2004, @rysFasMutationsNonHodgkins2019,
[[TOC]]
FAS encodes a cell surface receptor involved in the induction of apoptosis. FAS mutations are common in DLBCL and may be more frequent in primary gastric DLBCL.[@wohlfartFASCD95Mutations2004],[@schollMutationsRegionFAS2007] Mutations also occur in FL at a lower rate.[@morinFrequentMutationHistonemodifying2011] Although reported in one BL study,[@paneaWholeGenomeLandscape2019] overall the evidence for FAS mutations in BL remains sparse. Mutations in FAS often lead to a loss of function, making lymphoma cells resistant to Fas ligand-induced apoptosis, thereby allowing malignant cells to evade immune surveillance.[@rysFasMutationsNonHodgkins2019] In mouse models, Fas mutations led to a significantly shorter lymphoma-specific survival and reduced sensitivity to chemotherapy.[@rysFasMutationsNonHodgkins2019]
Driver mutations affecting this gene in FL/DLBCL have been experimentally demonstrated to cause a reduction or loss of function (LOF).[@wangFasFADDDeathDomain2010]
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.